Tag: Vertex Pharmaceuticals

Breakthrough CRISPR Gene Editing Trial Achieves 95% Cure Rate for Sickle Cell Disease in Adults

Vertex Pharmaceuticals' Phase III CRISPR trial cures 95% of adult sickle cell…

admin